Ostarine MK-2866 SARM Guide: Research, Uses and Cycle Information

Ostarine, MK-2866 and enobosarm are names used for the same investigational selective androgen receptor modulator. It is one of the most extensively researched compounds in the SARM category and has been evaluated in human studies involving lean body mass, physical function and muscle loss.

What Is Ostarine MK-2866?

Ostarine is a nonsteroidal selective androgen receptor modulator. The names Ostarine, MK-2866, enobosarm and GTx-024 all refer to the same compound.

It was developed for research into conditions involving muscle loss and declining physical function. Interest later expanded beyond medical research because of its interaction with androgen receptors in muscle and other tissues.

How Does Ostarine Work?

Ostarine binds to and activates androgen receptors. These receptors are involved in the regulation of muscle, bone and other androgen-responsive tissues.

The objective behind SARM development was to create nonsteroidal compounds with more tissue-selective activity than traditional full androgen-receptor agonists. Selective does not mean that a compound acts only in muscle or that effects elsewhere are impossible.

Human Research on Ostarine

A 12-week double-blind, placebo-controlled phase II study evaluated enobosarm in 120 healthy men over 60 years old and postmenopausal women. Participants received placebo or one of several daily enobosarm amounts ranging from 0.1 mg to 3 mg.

The researchers reported dose-related increases in total lean body mass. The 3 mg group also showed a statistically significant improvement in physical function measured through stair-climb performance.

A separate randomized study evaluated 1 mg and 3 mg of enobosarm in people experiencing muscle loss associated with cancer. Both enobosarm groups recorded significant increases in total lean body mass during the study period.

These trials support research interest in Ostarine and lean body mass. They do not establish the results of higher-dose bodybuilding use, cutting cycles or recreational SARM combinations.

Why Ostarine Is Discussed for Lean Mass and Cutting

Ostarine became popular within the performance market largely because controlled studies reported increases or preservation of lean body mass. This led to its use in discussions about cutting, recomposition and maintaining muscle during a calorie deficit.

Clinical research into lean body mass should not be interpreted as proof that Ostarine automatically burns fat or guarantees a particular physical transformation. Changes in training, nutrition, calorie intake and individual response remain major factors.

Ostarine and Muscle Preservation

Much of the formal enobosarm research has focused on maintaining or increasing lean tissue in populations at risk of muscle loss. This includes older adults, people with cancer-related muscle wasting and newer research involving body composition during weight reduction.

That research focus distinguishes Ostarine from SARMs with much smaller human evidence bases. However, the populations and amounts used in controlled trials differ from common non-medical SARM use.

Common Ostarine Cycle Discussions

Online SARM communities commonly discuss Ostarine cycles lasting approximately six to eight weeks, with daily amounts often discussed in the 10–25 mg range. These are community use patterns rather than clinically validated protocols.

Most established human muscle and body-composition studies used substantially lower amounts, commonly between 0.1 mg and 3 mg per day. Research findings from those studies cannot simply be transferred to the higher amounts promoted in performance-focused markets.

Does Ostarine Require PCT?

Ostarine can affect normal hormonal signalling, but the response is not identical for every person or cycle. The amount used, cycle duration, previous exposure and individual hormone levels can all influence the post-cycle response.

Shorter and lower-exposure cycles may be less suppressive than longer or higher-exposure cycles, but eight weeks is not a guaranteed cutoff. Blood testing before and after a cycle provides more useful information than relying only on cycle length or symptoms.

Customers comparing post-cycle options can review the SARM PCT and Post-Cycle Support category. The products listed there work through different mechanisms and should not be treated as interchangeable.

Ostarine Compared With Other SARMs

Ostarine is generally discussed as one of the more established SARMs because it has been evaluated in multiple human clinical programs. LGD-4033 and RAD-140 are different compounds with separate research histories, receptor profiles and commonly discussed uses.

The Liquid SARMs in Thailand category compares Ostarine with LGD-4033 Ligandrol, RAD-140 Testolone, S-4 Andarine and AC-262 Accadrine.

Is Ostarine Used in SARM Stacks?

Ostarine appears in several pre-built combinations because customers commonly compare it with Cardarine, RAD-140 and other performance compounds.

Using more than one compound creates a more complex cycle than using Ostarine alone. Each included product should be reviewed separately because the compounds do not share the same mechanism or research profile.

Available combinations can be compared in the SARM Stacks in Thailand category.

Ostarine Research Status

Ostarine remains an investigational compound. It has been evaluated in human clinical trials, but it is not approved as a general muscle-building, cutting or athletic-performance medicine.

Ostarine is also prohibited in tested sport under the World Anti-Doping Agency Prohibited List. Athletes subject to anti-doping rules should avoid exposure to products containing Ostarine, MK-2866, enobosarm or GTx-024.

Frequently Asked Questions

Are Ostarine, MK-2866 and Enobosarm the same compound?

Yes. Ostarine is the common market name, MK-2866 and GTx-024 are development codes, and enobosarm is the research name associated with the same compound.

Is Ostarine a real SARM?

Yes. Ostarine is a selective androgen receptor modulator. This differs from Cardarine and MK-677, which are commonly grouped with SARMs commercially but belong to different compound classes.

What did human Ostarine studies find?

Controlled human studies reported dose-related increases in lean body mass and, in one 12-week study, improved stair-climb performance at the highest studied amount.

How much Ostarine is in 1 ml?

In a liquid containing 25 mg per ml, one full millilitre contains 25 mg of Ostarine.

What Ostarine cycle length is commonly discussed?

Six-to-eight-week cycles are commonly discussed in non-medical SARM communities. This is an informal use pattern rather than a cycle length established through clinical trials.

Does every Ostarine cycle need PCT?

No single answer applies to every cycle. The amount, duration and individual hormonal response all matter, and relevant blood testing provides the clearest information.

Ostarine Research Sources

• Twelve-week placebo-controlled phase II enobosarm study
• Randomized enobosarm study in patients with cancer-related muscle loss
• ClinicalTrials.gov enobosarm muscle-wasting study record
• World Anti-Doping Agency Prohibited List